The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 12, 2019
Filed:
Jul. 31, 2013
Applicant:
Stealth Peptides International, Inc., Monaco, MC;
Inventors:
D. Travis Wilson, Newton, MA (US);
Mark Bamberger, South Glastonbury, CT (US);
Brian Blakey, Doylestown, PA (US);
Assignee:
Stealth Biotherapeutics Corp, Monaco, MC;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/22 (2006.01); A61K 31/40 (2006.01); A61K 38/07 (2006.01); A61K 45/06 (2006.01); A61K 31/366 (2006.01); A61K 31/404 (2006.01); A61K 31/505 (2006.01); A61K 31/215 (2006.01); A61K 31/351 (2006.01); A61P 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 38/07 (2013.01); A61K 31/215 (2013.01); A61K 31/22 (2013.01); A61K 31/351 (2013.01); A61K 31/366 (2013.01); A61K 31/40 (2013.01); A61K 31/404 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01); A61P 9/10 (2018.01);
Abstract
Disclosed herein are methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and, in some applications, a second active agent, to subjects in need thereof. The present technology relates to the treatment or prevention of atherosclerosis in mammals through the administration of a therapeutically effective amount of aromatic cationic peptides and, in some embodiments, a second active agent.